Archives
-
Belinostat (PXD101): From HDAC Biology to Translation
2026-08-31
Belinostat (PXD101) illustrates how pan-HDAC biology, rigorous response measurements, and model-aware assay design can strengthen translational cancer research in bladder and prostate systems.
-
Periostin Regulation in HER2-Positive Breast Cancer
2026-08-31
Labrèche and colleagues identify a context-dependent cross-talk mechanism in which FGFR, TGFβ, PKC, and PI3K/AKT signaling jointly regulate periostin expression in Neu-positive breast cancer cells. The findings clarify how epithelial tumor cells can acquire a stromal-like extracellular-matrix program and provide a framework for studying pathway-dependent heterogeneity in breast cancer.
-
Magnetic CAR-T Mimicry for Solid Tumors
2026-08-30
The Advanced Materials study introduces M-BiNanoAb, a magnetic bispecific nano-antibody that engages endogenous T cells in vivo and redirects them toward PDL1-positive solid tumors. Its value lies in combining local T-cell activation with externally guided trafficking, although the preclinical design still requires validation across tumor types, magnetic-field configurations, and safety models.
-
AAL-993: A Strategic Framework for Angiogenesis
2026-08-29
A mechanistic and translational guide to using AAL-993 as a selective VEGF receptor inhibitor in angiogenesis, melanoma, and carefully bounded glioma research programs.
-
Gasdermin C Rewires PDAC Stemness and Immunity
2026-08-28
This 2024 Advanced Science study identifies Gasdermin C as a noncanonical regulator of pancreatic ductal adenocarcinoma stemness, metastasis, and immune evasion. Its findings connect ADAM17-dependent GSDMC cleavage and nuclear localization to CXCL9-mediated immune remodeling, suggesting a route to improve responses to KRASG12D inhibition and PD-1 blockade.
-
BET Inhibition as a Translational Control Strategy
2026-08-28
A mechanistic and strategic guide to using (+)-JQ1 as a BET bromodomain inhibitor across cancer, inflammation, and reproductive biology, with emphasis on combination design, translational readouts, and experimental boundaries.
-
Erastin Ferroptosis Workflows for Cancer Models
2026-08-27
Build reproducible ferroptosis experiments with Erastin by combining genotype-aware dosing, fresh-solution handling, and orthogonal oxidative-stress readouts. The workflow also shows how findings from a glioblastoma GPR68–ATF4 study can sharpen assay design without conflating Erastin activity with a different inhibitor.
-
TAI-1 in RB1-Deficient Cancer Models
2026-08-27
TAI-1 is a potent Hec1 inhibitor that links mitotic disruption with cancer cell proliferation inhibition. This article translates its mechanism into assay decisions informed by new RB1-deficient retinal organoid research, while clearly separating evidence from hypothesis.
-
Telatinib (BAY 57-9352) Assay Guide
2026-08-26
Learn how Telatinib (BAY 57-9352), SKU A8550, can improve the design and interpretation of viability, proliferation, cytotoxicity, and angiogenesis assays. This scenario-based guide covers target selectivity, DMSO handling, dose-response optimization, phenotype interpretation, and practical product selection.
-
Cholecystokinin octapeptide ammonium: Assay Guide
2026-08-26
This scenario-driven guide explains how Cholecystokinin octapeptide ammonium (SKU C8717) can be incorporated into viability, proliferation, apoptosis, and immune-response workflows without confusing a bioactive peptide with a Cell Counting Kit-8 reagent. It covers receptor-aware controls, concentration selection, formulation limits, interpretation of metabolic data, and practical vendor-selection criteria.
-
Solanesol (B8776): Workflow and QC Guide
2026-08-25
Solanesol is a hydrophobic polyisoprenoid alcohol for membrane-related biochemical and pharmaceutical research, including apoptosis research, DNA damage and repair studies, and enzyme-focused workflows. This guide explains how to prepare and control the compound while defining why aqueous, ethanol-based, diagnostic, and clinical applications are inappropriate.
-
Human iPSC Sensory Neurons Model HSV-1 Latency
2026-08-25
A 2025 mBio study established a scalable human induced pluripotent stem cell-derived sensory neuron system that supports HSV-1 latency and experimentally induced reactivation. Its strength is the use of convergent virological, transcriptional, and chromatin-based criteria, providing a more human-relevant platform for studying neuron-intrinsic mechanisms and antiviral strategies.
-
Phalloidin (B7678): F-Actin Workflow Guide
2026-08-24
Phalloidin (B7678) provides selective F-actin binding and actin filament stabilization for endpoint cytoskeleton visualization in fixed or permeabilized samples. It is not a neutral live-cell reporter and is unsuitable for experiments requiring reversible actin binding or unperturbed cytoskeletal dynamics.
-
Sex Differences in Angiotensin II Hypertension
2026-08-24
Xue, Pamidimukkala, and Hay demonstrated that chronic angiotensin II infusion produces a much larger hypertensive response in conscious male than female mice. Telemetry, gonadectomy, baroreflex testing, and ganglionic blockade linked this difference to sex-dependent hormonal and autonomic regulation rather than baseline blood pressure.
-
Pemetrexed: Practical Workflows for Cancer Research
2026-08-23
Build reproducible antifolate experiments with pemetrexed disodium across viability, nucleotide-biosynthesis, and combination-treatment assays. This guide connects concentration selection and plate handling with DNA-repair-informed studies in non-small cell lung carcinoma research and malignant mesothelioma models.